Memantine Side Effects
>>>Help Community - Post Your Memantine Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Memantine Side Effects
Memantine Safety Reports reported to FDA
Total Memantine reports: 154.Memantine FDA safety alerts: No.
Reported deaths: 24 Reported hospitalizations: 103.
Take Memantine Side Effects Survey or Share Your Memantine Story.
Reported Memantine Side Effects: fall, condition aggravated, blood creatine phosphokinase increased, aspartate aminotransferase increased, cholelithiasis, agitation, depressed level of consciousness, dehydration, alanine aminotransferase increased, cerebral atrophy, anorexia.
More About Memantine.
If you have questions about Memantine, you can ask a Health Expert or Ask Patient Community about Memantine.
< Previous Showing 101-150 of 154 Next >
Memantine Side Effects Report #5147250-7Physician from UNITED STATES reported MEMANTINE problem on Oct 25, 2006. Female patient, weighting 98.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cerebrovascular accident, hypersomnia, hypertension, hypothyroidism, oral intake reduced, skin laceration, wound. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.
Memantine Side Effects Report #5148144-3
MEMANTINE problem was reported by a Consumer or non-health professional from SPAIN on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5150743-X
Health Professional from JAPAN reported MEMANTINE problem on Oct 31, 2006. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, depressed level of consciousness, fall, gait disturbance, restlessness, somnolence. MEMANTINE dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5154586-2
MEMANTINE problem was reported by a Health Professional from FRANCE on Oct 26, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: hepatic cirrhosis, hepatic neoplasm malignant. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with PERINDOPRIL ERBUMINE, POTASSIUM CHLORIDE, CACIT D. Patient was hospitalized. Patient died on 04/02/2004.
Memantine Side Effects Report #5154587-4
Health Professional from ITALY reported MEMANTINE problem on Oct 26, 2006. Female patient, 91 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with HALOPERIDOLE, ACEIL SALICILIATE OF LYSINE, ENALAPRIL MALEATE, ACETIL SALICILIC ACID, NITRENDIPINA, DONEPEZIL. Patient was hospitalized and became disabled. Patient recovered.
Memantine Side Effects Report #5156769-4
MEMANTINE problem was reported by a Consumer or non-health professional from SWITZERLAND on Nov 03, 2006. Female patient, 58 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: convulsion, grand mal convulsion, hypochloraemia, hypokalaemia, inappropriate antidiuretic hormone secretion, loss of consciousness. MEMANTINE dosage: 15 MG QD PO. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5156770-0
Consumer or non-health professional from SWEDEN reported MEMANTINE problem on Oct 30, 2006. Female patient, 83 years of age, weighting 154.3 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aggression, arteriosclerosis, cardiovascular disorder, fall, gastric disorder, hallucination, nephrosclerosis, oral intake reduced, pulmonary congestion. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with BEHEPAN, FOLACIN, KATAIPOS D, OXASCAND, HEMINEURIN, ZOPLIKON. Patient died on 11/14/2004.
Memantine Side Effects Report #5157908-1
MEMANTINE problem was reported by a Physician from UNITED STATES on Oct 31, 2006. Female patient, 79 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, respiratory arrest. MEMANTINE dosage: unknown. During the same period patient was treated with RISPERIDONE, RIVASTIGMINE. Patient died.
Memantine Side Effects Report #5157909-3
Physician from UNITED STATES reported MEMANTINE problem on Oct 31, 2006. Female patient, 89 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, intentional overdose. MEMANTINE dosage: unknown. During the same period patient was treated with VERAPAMIL, DONEPEZIL. Patient died.
Memantine Side Effects Report #5158519-4
MEMANTINE problem was reported by a Health Professional from BELGIUM on Nov 14, 2006. Female patient, 86 years of age, weighting 180.8 lb, was diagnosed with apathy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebral atrophy, leukoaraiosis, psychomotor hyperactivity. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with ATORVASTATIN CALCIUM, ASPIRIN, TRAZODONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5158779-X
Health Professional from SPAIN reported MEMANTINE problem on Nov 01, 2006. Male patient, 66 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with RISPERDAL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5165191-6
MEMANTINE problem was reported by a Health Professional from DENMARK on Nov 21, 2006. Female patient, 76 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: delirium. MEMANTINE dosage: 10 MG BID PO. Patient recovered.
Memantine Side Effects Report #5165691-9
Health Professional from GERMANY reported MEMANTINE problem on Nov 17, 2006. Female patient, 17 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram change, hypokinesia, vomiting. MEMANTINE dosage: 100 MG QD PO. During the same period patient was treated with ETHANOL, VERAPAMIL. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5169194-7
MEMANTINE problem was reported by a Physician from FRANCE on Dec 02, 2006. Female patient, 81 years of age, was diagnosed with dementia alzheimer's type, arteritis coronary and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: syncope. MEMANTINE dosage: unknown. During the same period patient was treated with INFLUENZA VACCINE, EXELON, CORVASAL. Patient died.
Memantine Side Effects Report #5172420-1
Health Professional from FRANCE reported MEMANTINE problem on Nov 14, 2006. Female patient, 70 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.
Memantine Side Effects Report #5172435-3
MEMANTINE problem was reported by a Health Professional from FRANCE on Nov 14, 2006. Male patient, 84 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bedridden, dysstasia, gait disturbance, somnolence. MEMANTINE dosage: 5 MG QD PO. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE, ASPIRIN, CITALOPRAM HYDROBROMIDE, ATARAX. Patient recovered.
Memantine Side Effects Report #5173225-8
Health Professional from BELGIUM reported MEMANTINE problem on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, agitation, blood glucose increased, cholecystitis acute, depressed level of consciousness, gait disturbance, glabellar reflex abnormal, glycosylated haemoglobin increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAM, PANTOZOL, DIAMICRON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5173228-3
MEMANTINE problem was reported by a Health Professional from ITALY on Nov 10, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, diplopia, disorientation, gamma-glutamyltransferase increased, mydriasis, ophthalmoplegia, strabismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.
Memantine Side Effects Report #5174418-6
Health Professional from FRANCE reported MEMANTINE problem on Nov 21, 2006. Male patient, 91 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea at rest, epstein-barr virus test positive, haemolytic anaemia, mycoplasma infection. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5179927-1
MEMANTINE problem was reported by a Health Professional from FRANCE on Nov 29, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.
Memantine Side Effects Report #5179948-9
Health Professional from ITALY reported MEMANTINE problem on Nov 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, computerised tomogram abnormal, dementia alzheimer's type, diplopia, disease progression, disorientation, eye movement disorder. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.
Memantine Side Effects Report #5187177-8
MEMANTINE problem was reported by a Health Professional from JAPAN on Dec 01, 2006. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, jaundice cholestatic, malnutrition, metastases to liver, metastases to lymph nodes, pancreatic neoplasm. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, AMLODIPINE BESYLATE, VALSARTAN. Patient was hospitalized. Patient died on 04/22/2006.
Memantine Side Effects Report #5190810-8
Pharmacist from ITALY reported MEMANTINE problem on Oct 26, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anal sphincter atony, electrocardiogram st segment abnormal, electroencephalogram abnormal, loss of consciousness, malaise, trismus. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, VALPROIC ACID. Patient recovered.
Memantine Side Effects Report #5193633-9
MEMANTINE problem was reported by a Health Professional from GERMANY on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.
Memantine Side Effects Report #5194108-3
Physician from UNITED STATES reported MEMANTINE problem on Dec 12, 2006. Female patient, 82 years of age, weighting 98.00 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: amnesia, arteriosclerosis, bedridden, blood pressure diastolic decreased, blood pressure inadequately controlled, cerebrovascular accident, fluid intake reduced, hypertension. MEMANTINE dosage: 28 MG QD. During the same period patient was treated with DONEPEZIL, NORVASC, FOLIC ACID. Patient was hospitalized. Patient died on 03/04/2006.
Memantine Side Effects Report #5196546-1
MEMANTINE problem was reported by a Health Professional from JAPAN on Dec 15, 2006. Female patient, 77 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: fall, immobile, pyrexia, tremor. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, PROPIVERINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5196547-3
Health Professional from FRANCE reported MEMANTINE problem on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.
Memantine Side Effects Report #5197636-X
MEMANTINE problem was reported by a Consumer or non-health professional from FRANCE on Dec 12, 2006. Female patient, 91 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: coma, confusional state, respiratory disorder. MEMANTINE dosage: unknown. During the same period patient was treated with POTASSIUM CHLORIDE, FORLAX, SERORAM, DIGOXIN, SINTROM. Patient recovered.
Memantine Side Effects Report #5198459-8
Health Professional from UNITED STATES reported MEMANTINE problem on Dec 20, 2006. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with cerebral atrophy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: aortic dilatation, blood urea increased, breath sounds abnormal, cardiac pacemaker insertion, dilatation atrial, fall, feeling abnormal, glomerular filtration rate decreased, haematocrit decreased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5302412-0
MEMANTINE problem was reported by a Health Professional from GERMANY on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arthritis, blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5380529-2
Consumer or non-health professional from GREECE reported MEMANTINE problem on June 18, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.
Memantine Side Effects Report #5383169-4
MEMANTINE problem was reported by a Health Professional from IRELAND on June 06, 2007. Female patient, 86 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, dialysis, renal failure, vasculitis. MEMANTINE dosage: unknown. Patient recovered.
Memantine Side Effects Report #5383861-1
Physician from UNITED STATES reported MEMANTINE problem on June 26, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: balance disorder, ecchymosis, face injury, fall. MEMANTINE dosage: 28 MG QD;PO. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, ARTHROTEC, TRIAMCINOLONE ACETONIDE, GALANTAMINE HYDROBROMIDE, GLUCOSAMINE CHONDROITIN. Patient recovered.
Memantine Side Effects Report #5385507-5
MEMANTINE problem was reported by a Health Professional from FRANCE on June 26, 2007. Male patient, 61 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: bronchospasm, condition aggravated. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with EXELON, FORADIL, MIFLASONE, STABLON, ASPIRIN, PRAVASTATIN. Patient recovered.
Memantine Side Effects Report #5385569-5
Consumer or non-health professional from GERMANY reported MEMANTINE problem on May 04, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood pressure systolic decreased, cardiogenic shock, chest pain, coronary artery disease, coronary artery occlusion, coronary artery stenosis, dyspnoea. MEMANTINE dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, RITALIN, DILTIAZEM, METOPROLOL SUCCINATE, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5391702-1
MEMANTINE problem was reported by a Health Professional from GERMANY on July 02, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, chest pain, cholecystitis, cholelithiasis, condition aggravated, heart rate increased, pyrexia. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOYXCHOLIC ACID, MIDODRINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5393009-5
Consumer or non-health professional from UNITED STATES reported MEMANTINE problem on July 06, 2007. Male patient, 62 years of age, was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac hypertrophy, cerebral atrophy, homicide, poisoning, unresponsive to stimuli. MEMANTINE dosage: 10 MG BID. During the same period patient was treated with DONEPEZIL, CLONAZEPAM, PROPOXYPHENE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE. Patient died.
Memantine Side Effects Report #5394930-4
MEMANTINE problem was reported by a Health Professional from GERMANY on July 09, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, blood creatine phosphokinase increased, cardiogenic shock, chest pain, coronary artery stenosis, dizziness, dyspnoea, ejection fraction decreased. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with DILTIAZEM, DONEPEZIL, RITALIN, METOPROLOL EXTENDED, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5403515-2
Health Professional from FRANCE reported MEMANTINE problem on July 16, 2007. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete. MEMANTINE dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.
Memantine Side Effects Report #5404679-7
MEMANTINE problem was reported by a Health Professional from GERMANY on Nov 14, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood disorder, chronic lymphocytic leukaemia, condition aggravated, fluid retention, hepatocellular damage, splenomegaly. MEMANTINE dosage: 10 MG BID PO. During the same period patient was treated with QUETIAPINE FUMARATE, TRAZODONE, LOXAPINE, ASPIRIN, RABEPRAZOLE, TEGRETOL, ACETAMINOPHEN. Patient recovered.
Memantine Side Effects Report #5404755-9
Health Professional from JAPAN reported MEMANTINE problem on July 24, 2007. Male patient, 90 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholecystitis, cholelithiasis, heart rate increased. MEMANTINE dosage: unknown. During the same period patient was treated with DONEPEZIL, AMBROXOL HYDROCHLORIDE, SENNA LEAF, RANITIDINE HYDROCHLORIDE, TEPRENONE, URSODESOXYCHOLIC ACID. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5405942-6
MEMANTINE problem was reported by a Physician from UNITED STATES on July 19, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, bacteria urine, blood pressure decreased, body temperature increased, cardiomegaly, dehydration, hypernatraemia. MEMANTINE dosage: unknown. During the same period patient was treated with LIPITOR, ALLERGRA, EXELON, PRILOSEC, CALCIUM CHLORIDE, CENTRIUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5406185-2
Physician from UNITED STATES reported MEMANTINE problem on July 26, 2007. Male patient, 85 years of age, weighting 183.0 lb, was diagnosed with atrophy and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood pressure increased, blood urea increased, bradycardia, dilatation atrial, dizziness, fall, haematocrit decreased, haemoglobin decreased. MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with DONEPEZIL, WARFARIN, SOTALOL HYDROCHLORIDE, GLYBURIDE AND METFORMIN, ACTOS, SIMVASTATIN, TERAZOSIN. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5421468-8
MEMANTINE problem was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 75 years of age, weighting 130.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, agitation, blood pressure decreased, body temperature increased, cardiomegaly, condition aggravated, dehydration, fall. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with LIPITOR, ALLEGRA, EXELON, PRILOSEC, CALCIUM, CENTRUM SILVER, ASPIRIN, GLYCOLAX. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5423129-8
Health Professional from UNITED KINGDOM reported MEMANTINE problem on June 22, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, unresponsive to stimuli. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.
Memantine Side Effects Report #5428334-2
MEMANTINE problem was reported by a Health Professional from UNITED KINGDOM on Aug 21, 2007. Male patient, 78 years of age, was diagnosed with dementia and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, fall, loss of consciousness, pain. MEMANTINE dosage: unknown. During the same period patient was treated with ASPIRIN, SOTALOL HYDROCHLORIDE, GLICLAZINE, FYBOGEL, SENNA, HYDROXOCOBALAMIN, DONEPEZIL, GALANTAMINE HYDROBROMIDE. Patient was hospitalized. Patient died on 06/30/2007.
Memantine Side Effects Report #5449459-1
Physician from ARGENTINA reported MEMANTINE problem on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, diabetic foot. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5451099-5
MEMANTINE problem was reported by a Health Professional from GERMANY on Aug 23, 2007. Male patient, 70 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: cholelithiasis, pancreatitis. MEMANTINE dosage: 10 MG BID PO. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5458193-3
Physician from ARGENTINA reported MEMANTINE problem on Aug 25, 2007. Female patient, 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, diabetes mellitus inadequate control, diabetic foot, localised infection, malaise, varicose vein. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with INSULIN, OLANZAPINE, PAROXETINE, DONEPEZIL, ALPRAZOLAM, OXYBUTYNIN CHLORIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5458219-7
MEMANTINE problem was reported by a Physician from ARGENTINA on Sept 07, 2007. Male patient, 75 years of age, weighting 140.0 lb, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: anxiety, cardiac arrest, cardiac failure. MEMANTINE dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL, EZOPICLONE. Patient died on 09/05/2007.
< Previous Showing 101-150 of 154 Next >
Drug Information: Memantine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a604006.html
mem'-an-teenWhy is this medication prescribed?
Memantine is used to treat the symptoms of Alzheimer's disease. Memantine is in a class of medications called NMDA receptor antagonists. It works by decreasing abnormal excitement in the brain. Memantine can help people with Alzheimer's disease to think more clearly and perform daily activities more easily, but it is not a cure and does not stop the progression of the disease.
How should this medicine be used?
Memantine comes as a tablet to take by mouth. It is usually taken once or twice a day with or without food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. To help you remember to take memantine, take it at around the same time(s) every day. Take memantine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Your doctor will probably start you on a low dose of memantine and gradually increase your dose, not more than once every week.
Memantine controls Alzheimer's disease but does not cure it. Continue to take memantine even if you feel well. Do not stop taking memantine without talking to your doctor.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking memantine,
- tell your doctor and pharmacist if you are allergic to memantine or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: acetazolamide (Diamox); amantadine (Symmetrel); brinzolamide (Azopt); cimetidine (Tagamet); dextromethorphan (Robitussin, others); dichlorphenamide (Daranide); dorzolamide (Trusopt); methazolamide (GlaucTabs, Nepatazane); nicotine (Nicoderm, Nicorette, others); potassium citrate and citric acid (Cytra-K, Polycitra-K); ranitidine (Zantac); sodium bicarbonate (Soda Mint, baking soda); sodium citrate and citric acid (Bicitra, Oracit); and quinidine (Quinaglute, Quinidex). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had asthma, seizures, kidney disease, or repeated urinary tract infections.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking memantine, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking memantine.
- you should know that memantine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.
What special dietary instructions should I follow?
Tell your doctor if you are a vegetarian or if you usually eat large amounts of citrus fruits, vegetables, beans, or peas. Your doctor will tell you if you need to change your diet. If you do not regularly eat these foods, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Memantine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- extreme tiredness
- dizziness
- confusion
- headache
- sleepiness
- constipation
- vomiting
- pain anywhere in your body, especially your back
- coughing
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
- shortness of breath
- hallucination (seeing things or hearing voices that do not exist)
Memantine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- restlessness
- hallucination (seeing things or hearing voices that do not exist)
- sleepiness
- loss of consciousness
What other information should I know?
Keep all appointments with your doctor.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|